ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,852.77
      -0.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Processa Pharmaceuticals Inc (PCSA)

      7. Processa Pharmaceuticals Inc (PCSA) News

      PCSA

      Processa Pharmaceuticals (PCSA)

      Processa Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PCSA
      DateTimeSourceHeadlineSymbolCompany
      04/30/20248:00AMGlobeNewswire Inc.Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical ResearchNASDAQ:PCSAProcessa Pharmaceuticals Inc
      04/11/20248:00AMGlobeNewswire Inc.Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b TrialNASDAQ:PCSAProcessa Pharmaceuticals Inc
      03/28/20248:15AMGlobeNewswire Inc.Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
      03/25/20248:15AMGlobeNewswire Inc.Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual MeetingNASDAQ:PCSAProcessa Pharmaceuticals Inc
      02/21/20245:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      02/21/20248:15AMGlobeNewswire Inc.Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
      02/14/20241:00PMGlobeNewswire Inc.Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
      02/06/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      02/06/20248:30AMGlobeNewswire Inc.Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:PCSAProcessa Pharmaceuticals Inc
      02/01/20246:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
      02/01/20244:22PMGlobeNewswire Inc.Processa Pharmaceuticals Announces Closing of $7.0 Million Public OfferingNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/31/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/30/202410:46AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/29/20244:15PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/29/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/26/20249:04AMGlobeNewswire Inc.Processa Pharmaceuticals Announces Pricing of $7.0 Million Public OfferingNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/25/20248:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/25/20248:30AMGlobeNewswire Inc.Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 DosesNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/19/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/19/20247:45AMGlobeNewswire Inc.Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast CancerNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/18/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/18/20247:45AMGlobeNewswire Inc.Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock SplitNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/08/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      01/02/20245:06PMGlobeNewswire Inc.Processa Pharmaceuticals to Present at the Biotech Showcase 2024NASDAQ:PCSAProcessa Pharmaceuticals Inc
      12/29/20238:55AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PCSAProcessa Pharmaceuticals Inc
      12/19/20239:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      12/19/20239:00AMGlobeNewswire Inc.Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over CapecitabineNASDAQ:PCSAProcessa Pharmaceuticals Inc
      12/13/20239:00AMGlobeNewswire Inc.Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation CapecitabineNASDAQ:PCSAProcessa Pharmaceuticals Inc
      12/05/20235:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
      11/30/20238:15AMGlobeNewswire Inc.Processa Pharmaceuticals to Present at the MedInvest Oncology Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:PCSA